| Symbol | Company | Weighting |
|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP USD | 4.88% |
| AKRO | AKERO THERAPEUTICS INC | 4.80% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 3.24% |
| ARGX | ARGENX SE ADR | 2.98% |
| NTRA | NATERA INC | 2.84% |
| ISRG | INTUITIVE SURGICAL INC | 2.79% |
| BSX | BOSTON SCIENTIFIC | 2.75% |
| MCK | MCKESSON CORP | 2.66% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.61% |
| ALKS | ALKERMES INC | 2.50% |
| HCA | HCA HOLDINGS INC | 2.28% |
| SYK | STRYKER CORP | 2.26% |
| TARS | TARSUS PHARMACEUTICALS | 2.24% |
| EXAS | EXACT SCIENCES CORP | 2.22% |
| SNY | SANOFI- AVENTIS- ADR | 2.14% |
| RNA | AVIDITY BIOSCIENCES INC | 2.05% |
| NUVL | NUVALENT INC | 2.04% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 2.02% |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.89% |
| LNTH | LANTHEUS HOLDINGS INC | 1.86% |
| IDXX | IDEXX LABS CORP | 1.85% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.85% |
| ZTS | ZOETIS INC | 1.79% |
| IONS | IONIS PHARMACEUTICALS INC | 1.79% |
| AZN | ASTRAZENECA PLC-ADR | 1.77% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.71% |
| EW | EDWARDS LIFESCIENCES CORP | 1.71% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.68% |
| AMGN | AMGEN CORP | 1.62% |
| LLY | ELI LILLY CORP | 1.50% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.49% |
| ELV | ELEVANCE HEALTH INC | 1.48% |
| BDX | BECTON DICKINSON & CO | 1.42% |
| DHR | DANAHER CORP | 1.39% |
| DNLI | DENALI THERAPEUTICS INC. | 1.32% |
| DXCM | DEXCOM INC | 1.26% |
| REGN | REGENERON PHARMACEUTICALS | 1.25% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.22% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.20% |
| MRK | MERCK & CO. NEW | 1.14% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.13% |
| UNH | UNITEDHEALTH GROUP INC | 1.12% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 1.07% |
| BIIB | BIOGEN INC | 1.04% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.04% |
| CYTK | CYTOKINETICS INC | 1.03% |
| NVO | NOVO NORDISK A/S | 1.01% |
| AVTR | AVANTOR, INC. | 0.99% |
| IMVT | IMMUNOVANT INC | 0.93% |
| TNDM | TANDEM DIABETES CARE INC | 0.91% |
| PCVX | VAXCYTE INC | 0.89% |
| DYN | DYNE THERAPEUTICS, INC. | 0.84% |
| APLS | APELLIS PHARMACEUTICALS INC | 0.84% |
| VKTX | VIKING THERAPEUTICS, INC. | 0.80% |
| ACHC | ACADIA HEALTHCARE CO INC | 0.71% |
| XNCR | XENCOR INC. | 0.64% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.59% |
| KURA | KURA ONCOLOGY INC | 0.55% |
| ARVN | ARVINAS INC USD | 0.38% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.